Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Hematology

C-Reactive Protein-To-Albumin Ratio Is an Independent Poor Prognosis and Improving NCCN-Ipi Score in Newly Diagnosed Diffuse Large B-Cell Lymphoma: A Clinical Analysis of 414 Cases

Hematological Oncology

English

RESPONSE TO NIVOLUMAB AS ≥3rd LINE THERAPY IN PTS WITH RELAPSED/REFRACTORY CLASSICAL HODGKIN'S LYMPHOMA (CHL) AND ITS IMPACT ON QUALITY OF LIFE IN RESPONDERS AND NONRESPONDERS

Hematological Oncology

English

Response of Diffuse Large B-Cell Lymphoma Treated With R-Chop and Prognostic Factors Associated: A Single Institution Analysis in Lima, Peru

Hematological Oncology

English

Abnormalities in Microrna Expression Signature Can Contribute to the Genome Instability and Failure of Dna Repair Mechanisms in Case of Diffuse Large B-Cell Lymphoma

Hematological Oncology

English

Simultaneous Diffuse Large B-Cell Lymphoma (Dlbcl) and Follicular Lymphoma (Fl) at the Diagnosis Has Similar Outcome as DLBCL

Hematological Oncology

English

Efficiency and Safety of Stem Cell Mobilization Following GDP Salvage in Patients With Relapsed or Refractory Lymphoma

Hematological Oncology

English

Long-Term Efficacy and Safety of Lenalidomide Maintenance in Patients With Relapsed Diffuse Large B-Cell Lymphoma Who Are Not Eligible for Autologous Transplantation (Asct)

Hematological Oncology

English

Real-World Bendamustine Use in Relapsed/Refractory Diffuse Large B-Cell Lymphoma (R/R Dlbcl)

Hematological Oncology

English

Outcome of Diffuse Large B-Cell Lymphoma in Patients Over the Age of 70 Years: Real-World Experience in a Large U.K. District General Hospital

Hematological Oncology

English

TachoSil Use in Abdominal Surgery: A Review

Journal of Blood Medicine

Hematology

2011

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Hematology

C-Reactive Protein-To-Albumin Ratio Is an Independent Poor Prognosis and Improving NCCN-Ipi Score in Newly Diagnosed Diffuse Large B-Cell Lymphoma: A Clinical Analysis of 414 Cases

RESPONSE TO NIVOLUMAB AS ≥3rd LINE THERAPY IN PTS WITH RELAPSED/REFRACTORY CLASSICAL HODGKIN'S LYMPHOMA (CHL) AND ITS IMPACT ON QUALITY OF LIFE IN RESPONDERS AND NONRESPONDERS

Response of Diffuse Large B-Cell Lymphoma Treated With R-Chop and Prognostic Factors Associated: A Single Institution Analysis in Lima, Peru

Abnormalities in Microrna Expression Signature Can Contribute to the Genome Instability and Failure of Dna Repair Mechanisms in Case of Diffuse Large B-Cell Lymphoma

Simultaneous Diffuse Large B-Cell Lymphoma (Dlbcl) and Follicular Lymphoma (Fl) at the Diagnosis Has Similar Outcome as DLBCL

Efficiency and Safety of Stem Cell Mobilization Following GDP Salvage in Patients With Relapsed or Refractory Lymphoma

Long-Term Efficacy and Safety of Lenalidomide Maintenance in Patients With Relapsed Diffuse Large B-Cell Lymphoma Who Are Not Eligible for Autologous Transplantation (Asct)

Real-World Bendamustine Use in Relapsed/Refractory Diffuse Large B-Cell Lymphoma (R/R Dlbcl)

Outcome of Diffuse Large B-Cell Lymphoma in Patients Over the Age of 70 Years: Real-World Experience in a Large U.K. District General Hospital

TachoSil Use in Abdominal Surgery: A Review